About Pulvinar Neuro
Pulvinar Neuro is a company based in Durham (United States) founded in 2016 was acquired by Alpha-Stim in March 2022. Pulvinar Neuro offers products and services including XCSITE-RD and Next-Generation Brain Stimulation Devices.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pulvinarneuro Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$55 K (USD), Grant
Sep 01, 2021
-
Investors
HHS
& 1 more
-
Employee Count
Not available
-
Acquired by
Alpha-Stim
(Mar 21, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pulvinar Neuro
Pulvinar Neuro offers a comprehensive portfolio of products and services, including XCSITE-RD and Next-Generation Brain Stimulation Devices.
A transcranial stimulation device is offered for double-blind research in tDCS and tACS applications.
Advanced devices are provided that enable custom waveforms and feedback-controlled stimulation based on EEG features for research purposes.
People of Pulvinar Neuro
Unlock access to complete
Unlock access to complete
Funding Insights of Pulvinar Neuro
Investors in Pulvinar Neuro
Pulvinar Neuro has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Alpha-Stim.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Non-drug electrotherapy devices for pain and anxiety are developed.
|
Locked | Locked | Locked |
Investor details for Pulvinar Neuro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pulvinar Neuro
Investment portfolio details for Pulvinar Neuro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pulvinar Neuro
Detailed financials for Pulvinar Neuro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pulvinar Neuro Comparisons
Peer comparison for Pulvinar Neuro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pulvinar Neuro
Detailed competitors of Pulvinar Neuro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pulvinar Neuro
Complete news archive for Pulvinar Neuro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pulvinar Neuro
Pulvinar Neuro was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Pulvinar Neuro is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Pulvinar Neuro was established in 2016 in Durham, United States. Focus is placed on the biotechnology sector, where drugs targeting neuroscience conditions are developed. Research services are offered to support scientific investigations in this field. Operations center on advancing therapeutic solutions for neurological applications, with activities conducted primarily in the United States. The companys domain, pulvinarneuro.com, facilitates access to these resources.
Pulvinar Neuro offers XCSITE-RD and Next-Generation Brain Stimulation Devices.
Pulvinar Neuro has 2 investors. Key investors include HHS, and Alpha-Stim.